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Hypothesis / aims of study 
Acetylcholine (ACh), and other functional transmitters such as ATP and prostaglandins, are 
released from the bladder mucosa when subjected to stretch or changes of transmural 
pressure.  However, for ACh its precise cellular origin, routes of release and its function after 
release have not been fully characterised. The study aimed to quantify and characterise ACh 
release from freshly isolated urothelial cells when subjected to changes of shear stress . 
 
Study design, materials and methods 
Guinea-pigs were euthenised by cervical dislocation, the  bladder was immediately removed 
and the mucosa dissected free of the detrusor layer by blunt dissection. Incubation of the 
mucosa in Trypsin EDTA (0.5g.l-1 Trypsin/ 0.2g.l-1 EDTA, Sigma) for 40 min at 37°C followed 
by gentle trituration, liberated urothelial cells. Cells were labelled with cytokeratin-20 (CK-20) 
to indicate their urothelial origin. An improved Neubauer haemocytometer stage was used to 
count cell number in a suspension and the radius of cells was measured from light 
micrographs of cell suspensions (x40).  For experiments cells were resuspended at room 
temperature in Ca-free Tyrode’s solution (pH 7.4 buffered with 24 mM NaHCO3/5% CO2) and 
incubated for at least 90 minutes before use. Mechanical stimuli were applied by pipetting 20 
µl of the 45 µl cell suspension a set number of times and immediately removing and freezing 
20 µl of the suspension for later analysis. ACh was measured with an Amplex®Red 
ACh/acetylcholinesterase assay kit (Invitrogen). Fluorescence (590 nm) was measured after 
excitation at 544 nm using a BMG FLUOstar Omega multi-mode plate reader. ACh standards 
were included in each plate.  ATP was measured with a lucifererin-luciferase assay (FL-AAM, 
Sigma) and a luminometer (GloMax 20/20; Promega) against a calibration curve over the 
range 10-13 – 10-7 M. All agents were form Sigma UK and all interventions were tested against 
vehicle controls. Data are mean±SD and differences in data sets were examined using 
Student’s t-tests; the null hypothesis was rejected at p<0.05 
 
Results 
Isolated cell viability was tested by Trypan Blue exclusion (90.2±0.4% excluded, n=121) and 
nearly all cells (95±2, n=4) labelled for CK-20. Suburothelial and detrusor cells did not label 
for CK-20 in bladder sections. Cell size was conveniently described by three Gaussian 
distributions with diameters of: 10.9±0.5 µm (basal cells); 18.5±0.6 µm (intermediate cells); 
30.6±2.5 µm (umbrella cells). Imposition of shear stress led to ACh and ATP release,   
however, the pattern of this release was very different (Fig 1): the amount of ACh release was 
smaller and maximal after just one intervention, whereas ATP was a continuous function of 
the number of interventions.  Basal levels (x0, fig 1) of ACh and ATP were 45.5±13.2 
pmol/105 cells and 413±228 pmol/105 cells, respectively (n=3). 
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Figure 1.  ACh and ATP 
release from isolated 
urothelial cells after 1-50 
shear stress interventions. 
Note the linear ordinate on 
the ACh relation (left) and 
the logarithmic ordinate for 
the ATP relation (right) 
 
Shear-stress evoked ACh release was unaffected by brefeldin-A (10-5 g.ml-1; n=9) that 
attenuates vesicle-mediated release and the gap junction blocker, carbenoxolone (50 µM; 
n=13). Additional experiments showed that brefeldin and carbenoxolone were effective in 
reducing shear-stress induced ATP release (to 0.75±0.08 and 0.71±0.07 of control (=1.0), 
respectively). 
 
However, the CFTR channel inhibitor, CFTRinh-172 did reduce ACh release, in a dose-
dependent manner, with a maximum effect to reduce release to 0.60±0.11 (n=13) of control, 
with an IC50 of 3.4±0.7 µM. 
 
 
 
The effect of muscarinic receptor agonists and antagonists on shear-stress induced ATP 
release was tested.  Carbachol (10 µM, n=6) increased shear-stress induced ATP release to 
1.42±0.20 of control. By contrast, the M2-selective antagonist methoctramine reduced ATP 
release in a dose-dependent manner to a maximum of 0.73±0.06 (n=7) of control and with a  
pIC50 of 6.60±0.25, n=5 (IC50=-logIC50, mean IC50 = 250 nM). The M3-selective antagonist 4-
DAMP also reduced ATP release but to a smaller maximal effect; 0.87±0.04 (n=5) of control; 
pIC50 = 7.01±0.21; mean IC50 99 nM; n=5.  CFTRinh-172 (20 µM) also significantly reduced 
ATP release to 0.60 ± 0.10 of control (n=8). 
 
Interpretation of results 
Acetylcholine is released in significant quantities from freshly-isolated, viable urothelial cells.  
Moreover, maximum ACh release is achieved by smaller external physical forces than ATP 
release.  The route of ACh release is different from that of ATP release, a major fraction of 
ACh release is via a CFTR-like channel, whilst brefeldin-A and carbenoxolone affect ATP, but 
not ACh, release.  The actions of carbachol, antimuscarinic agents and a CFTR channel 
inhibitor on ACh release has permitted the proposal of a hypothesis namely: stress-induced 
ACh release from urothelial cells regulates further release of ATP. This mechanism has a 
high gain, and regulation of the ACh fraction of the transmitter release pathway confers a high 
sensitivity to the overall release of stress-induced urothelial transmitters. The pIC50 values of 
methoctramine and 4-DAMP for their action on ATP release reflect a profile nearer to the M2 
rather than the M3 receptor [1], but a more detailed subtype profiling is required. 
 
Concluding message 
Acetylcholine is released from urothelial cells when subjected to shear stress by a novel 
route, different from ATP release.  It is hypothesised that ACh thus released controls the 
release of ATP from urothelial cells.  This pathway may contribute to the action of 
antimuscarinic agents in their ability to reduce symptoms of LUTS and painful bladder 
syndrome through attenuation of sensory afferent pathways. 
 
Figure 2. The effect of 
CFTRinh-172 on stress-
induced ACh release.   
Left: paired results of 13 
experiments in the vehicle 
(DMSO) or CFTRinh-172.  
Right: dose response curve 
of CFTRinh-172 on stress-
induced ACh release. 
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